In this Issue:
Predicting postchemotherapy ovarian function
Breast cancer in Wilms tumour survivors
Iniparib disappoints in metastatic TNBC
Disease stabilisation after AI withdrawal
Dose-dense paclitaxel in axillary node-positive early disease
Lymph node involvement defines chemotherapy regimen
Breast cancer during follow-up and progression
Molecular testing rationalises systemic therapy
Implant reconstruction: before vs after postmastectomy RT
Eribulin: survival benefits in adjuvant and metastatic settings
Please login below to download this issue (PDF)